title: [Sjögren's syndrome. Current aspects from a rheumatological point of view].
abstract: Sjögren's syndrome is an autoimmune disease of the exocrine glands characterized by the leading symptoms of keratoconjunctivitis and stomatitis sicca based on a complex pathogenesis. The prevalence is about 0.5-1%; primary Sjögren's syndrome is differentiated from secondary Sjögren's syndrome associated with other autoimmune disorders. The diagnosis is established by the presence of subjective complaints and objective evidence of sicca symptoms, anti-Ro(SSA)/La(SSB) antibodies, and/or focal lymphocytic infiltration of the glandular tissue. In addition to the typical sicca symptomatology, which is managed symptomatically by substitution and stimulation therapy, some patients exhibit extraglandular manifestations. Complaints involving the musculoskeletal system and inner ear dominate and are treated by the rheumatologist. The indication for base therapy is tailored to individual needs, but the efficacy of this approach has not been established in studies. About 5-10% of the patients with primary Sjögren's syndrome develop a B-cell non-Hodgkin's lymphoma. The disease requires interdisciplinary management including, among others, ophthalmologists, dentists, and otorhinolaryngologists, depending on the clinical picture.
authors.affiliation: Reha-Zentrum Bad Aibling, Deutsche Rentenversicherung Bund, Rheumazentrum - AHB, Kolbermoorer Strasse 56, 83043 Bad Aibling, Deutschland. Drmed.Christian.Tomiak@drv-bund.de
authors.forename: C
authors.initials: C
authors.lastname: Tomiak
authors.forename: T
authors.initials: T
authors.lastname: Dörner
mesh_terms: D000974:Antibodies, Antinuclear / Q000097:blood; D001324:Autoantigens / Q000276:immunology; D003299:Cooperative Behavior; D003937:Diagnosis, Differential; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D010348:Patient Care Team; D012261:Ribonucleoproteins / Q000276:immunology; D012307:Risk Factors; D012859:Sjogren's Syndrome / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D014987:Xerostomia / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D000097585:SS-B Antigen
chemical_list: D000974:Antibodies, Antinuclear; D001324:Autoantigens; D012261:Ribonucleoproteins; D000097585:SS-B Antigen; C035356:SS-A antibodies